Results 311 to 320 of about 17,238,138 (390)

Implementation of a Cancer Navigation Intervention for Newly Diagnosed Survivors of Breast Cancer: Protocol for a Randomized Controlled Trial.

JMIR Res Protoc
D'Souza MS, Gidda R, Smith M, Swaminadhan A, Strank AJ, Nairy A.   +5 more
europepmc   +1 more source

Integrated multi-omics and machine learning highlight PTM-related genes as potential biomarkers in endometrial cancer. [PDF]

Transl Oncol
Zhou X.
europepmc   +1 more source

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

Predictors of survival among cervical cancer patients in Swaziland (Eswatini): A population-based analysis in a resource-limited setting (2016-2024). [PDF]

PLOS Glob Public Health
Msibi SS, Lopez C, Khumalo FN, Su LJ.
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Spermatic cord metastasis from prostatic cancer.

, 2003
AS Bawa, Rajesh Singh, Bansal Vk, Rajpal Singh Punia   +3 more
openalex   +1 more source

Projection du fardeau du cancer au Canada en 2026. [PDF]

CMAJ
Brenner DR, Gillis J, Demers AA, Ellison LF, Ng C, Zhang SX, Finley C, Fitzgerald N, Saint-Jacques N, Shack L, Turner D, Urquhart R, Woods RR, pour le Comité consultatif des statistiques canadiennes sur le cancer.   +13 more
europepmc   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source